Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 29 results
Author
Title
Type
[
Year
]
Filters:
Author
is
Scherl, Ellen J
[Clear All Filters]
2002
Scherl EJ
. 2002.
Irritable-inflammatory bowel disease: recognizing a new overlap syndrome and an enigma wrapped inside a puzzle.
.
Inflamm Bowel Dis. 8(5):373-4.
2007
Harris A
,
Eswaran S
,
Bosworth B
,
Gambarin-Gelwan M
,
Scherl EJ
. 2007.
Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.
.
Gastroenterol Hepatol (N Y). 3(11):875-7.
2008
Poppers DM
,
Scherl EJ
. 2008.
Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.
.
Inflamm Bowel Dis. 14(1):106-13.
2010
Weinstock LB
,
Bosworth BP
,
Scherl EJ
,
Li E
,
Iroku U
,
Munsell MA
,
Mullen GE
,
Walters AS
. 2010.
Crohn's disease is associated with restless legs syndrome.
.
Inflamm Bowel Dis. 16(2):275-9.
Scherl EJ
,
Kumar S
,
Warren RU
. 2010.
Review of the safety and efficacy of ustekinumab.
.
Therap Adv Gastroenterol. 3(5):321-8.
2012
Craven M
,
Egan CE
,
Dowd SE
,
McDonough SP
,
Dogan B
,
Denkers EY
,
Bowman D
,
Scherl EJ
,
Simpson KW
. 2012.
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease.
.
PLoS One. 7(7):e41594.
2013
Kothary V
,
Scherl EJ
,
Bosworth B
,
Jiang Z-D
,
Dupont HL
,
Harel J
,
Simpson KW
,
Dogan B
. 2013.
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
.
Antimicrob Agents Chemother. 57(2):811-7.
Montrose DC
,
Scherl EJ
,
Bosworth BP
,
Zhou XKathy
,
Jung B
,
Dannenberg AJ
,
Hla T
. 2013.
S1P₁ localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
.
J Lipid Res. 54(3):843-51.
2014
Longman RS
,
Diehl GE
,
Victorio DA
,
Huh JR
,
Galan C
,
Miraldi ER
,
Swaminath A
,
Bonneau R
,
Scherl EJ
,
Littman DR
. 2014.
CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
.
J Exp Med. 211(8):1571-83.
Zhang N
,
Yantiss RK
,
Nam H-S
,
Chin Y
,
Zhou XKathy
,
Scherl EJ
,
Bosworth BP
,
Subbaramaiah K
,
Dannenberg AJ
,
Benezra R
. 2014.
ID1 is a functional marker for intestinal stem and progenitor cells required for normal response to injury.
.
Stem Cell Reports. 3(5):716-24.
Dogan B
,
Suzuki H
,
Herlekar D
,
R Sartor B
,
Campbell BJ
,
Roberts CL
,
Stewart K
,
Scherl EJ
,
Araz Y
,
Bitar PP
et al.
. 2014.
Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation.
.
Inflamm Bowel Dis. 20(11):1919-32.
2015
DeFilippis EM
,
Barfield E
,
Leifer D
,
Steinlauf A
,
Bosworth BP
,
Scherl EJ
,
Sockolow R
. 2015.
Cerebral venous thrombosis in inflammatory bowel disease.
.
J Dig Dis. 16(2):104-8.
Huang C
,
Haritunians T
,
Okou DT
,
Cutler DJ
,
Zwick ME
,
Taylor KD
,
Datta LW
,
Maranville JC
,
Liu Z
,
Ellis S
et al.
. 2015.
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
.
Gastroenterology. 149(6):1575-86.
Gerbarg PL
,
Jacob VE
,
Stevens L
,
Bosworth BP
,
Chabouni F
,
DeFilippis EM
,
Warren R
,
Trivellas M
,
Patel PV
,
Webb CD
et al.
. 2015.
The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
.
Inflamm Bowel Dis. 21(12):2886-96.
Dassopoulos T
,
Cohen RD
,
Scherl EJ
,
Schwartz RM
,
Kosinski L
,
Regueiro MD
. 2015.
Ulcerative Colitis Care Pathway.
.
Gastroenterology. 149(1):238-45.
2016
DeFilippis EM
,
Longman R
,
Harbus M
,
Dannenberg K
,
Scherl EJ
. 2016.
Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.
.
Curr Gastroenterol Rep. 18(3):13.
DeFilippis EM
,
Tabani S
,
Warren RU
,
Christos PJ
,
Scherl EJ
. 2016.
Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.
.
Dig Dis Sci. 61(1):215-20.
2017
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
2018
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
Dogan B
,
Belcher-Timme HFacey
,
Dogan EI
,
Jiang Z-D
,
Dupont HL
,
Snyder N
,
Yang S
,
Chandler B
,
Scherl EJ
,
Simpson KW
. 2018.
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
.
FEMS Microbiol Lett. 365(22)
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Dogan B
,
Fu J
,
Zhang S
,
Scherl EJ
,
Simpson KW
. 2018.
Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.
.
J Antibiot (Tokyo). 71(5):485-494.
2020
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
Zhang S
,
Dogan B
,
Guo C
,
Herlekar D
,
Stewart K
,
Scherl EJ
,
Simpson KW
. 2020.
Short Chain Fatty Acids Modulate the Growth and Virulence of Pathosymbiont and Host Response.
.
Antibiotics (Basel). 9(8)
Panaccione R
,
Danese S
,
Sandborn WJ
,
O'Brien CD
,
Zhou Y
,
Zhang H
,
Adedokun OJ
,
Tikhonov I
,
Targan S
,
Abreu MT
et al.
. 2020.
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
.
Aliment Pharmacol Ther. 52(11-12):1658-1675.
1
(current)
2
next ›
last »